Search
 

Expertise

Banking & Finance
09d297d4-b21a-476a-9b3b-003a84feb441
Competition & EU
25ea855f-256f-44d8-90a1-0b71ccff46a9
Consumer Products
fdaeb40c-cf77-4914-a58c-1a03c335c397
Corporate
93cf37d6-d493-442a-9cd7-0d57416f97c3
Dispute Resolution
fe8256ee-187c-45e6-9cf4-0b2c3c558cb6
Employment & Pensions
727b3962-b901-46cf-9b6c-11c8b49f7ba3
Energy
8032f7e7-b600-4a7e-b05f-217745bbeaea
Environment
82c47370-7851-4c94-8931-77eaeccddc75
Hotels & Leisure
144db80f-750b-4ffc-af8d-1e51bddb25cd
Infrastructure & Project Finance
e33d3821-444d-4f75-82c5-1c61164535de
Insolvency & Restructuring
07bc1489-8bcb-43ff-94ba-6f91692be275
Intellectual Property
18a90dbb-4bfd-43e6-8f44-1436e1e7bebb
Lifesciences
1d002eab-a7e2-42b7-b5c3-1a79f5fc89bf
Patrimonial Law
6aa04838-7317-4b31-93ec-31586f44c70a
Private Equity
68a84dbf-6877-4fce-a99b-056086c84f40
Public Law
b723a9d9-39d9-4886-b955-3436d3518969
Real Estate & Construction
6b852b66-ccd6-462b-bc15-11d01c45a1c3
Tax
d0a8bec9-3d68-4e94-b7c8-1306db4bf9df
Technology, Media and Telecoms
f72f2c83-374d-45bc-91f4-1a6fa7e7cddb

France

Lifesciences


 or  

The legal environment surrounding the pharmaceutical industry, such as medical devices, is changing every day: reassessment of the profit/risk ratio, pressure due to restrictions on social spending, increased EU and international restrictions, the public authorities' growing tendency to unilaterally replace traditional policies by unilateral measures are factors behind the major changes in the legal environment.

These developments subsequently trigger substantial changes in relations between manufacturers, health care providers, distributors (wholesalers or pharmacies) or patients.
Companies are consequently required to monitor developments and raise new and increasingly complex questions on a day-to-day basis. Highly specialized advisory services are vital in this new legal environment.

 

Our practices areas

  • Regulatory
    Providing analysis on regulatory rules in general and in particular relating to drugs, medical devices, veterinary medicines, phytosanitary products, cosmetics products and food supplements
    Providing analysis on clinical trials
    Providing analysis on data privacy in the context of health data
    Providing analysis and assistance in the scope of promotional and advertising campaigns for healthcare products
    Providing assistance with managing post-market licences (health research, risk management plans, etc.)
    Examining the validity of decisions taken relating to market licences (prescription restrictions, generic market licences, etc)

  • Corporate transactions/Licensing
    Handling a diverse range of transactions and due diligences for pharmaceutical and health clients
    Providing assistance relating to setting up business in France, company take-overs or changes in legal form

  • Price & Reimbursement
    Examining the validity of reimbursement procedures (scientific assessments and advices issued by the High Authority for Health - HAS)
    Examining the validity of decisions taken by the Healthcare Products Economic Committee (Comité économique des produits de santé - CEPS) relating to pricing
    Providing assistance for sales to hospitals (hospital procurement contracts, hospital pricing practices and sales practices from a competition law perspective)

  • Compliance
    Anti Bribery/FCPA
    Good promotional practices and anti-gifts rules

  • Product liability
    Providing assistance and court representation for industrial liability lawsuits

  • Antitrust/competition
    Providing assistance in the scope of managing sales policy (choice of distribution channels, management of relations with wholesalers and commercial cooperation agreements, problems specific to distributing medical systems, etc.)
    Parallel imports and issues relating to compliance with competition rules

  • Tax/Customs
    Providing assistance in litigation relating to the various taxes specific to the healthcare product sector (additional tax on direct sales, tax on the promotion of medical information, sales tax, etc.)
    Providing advice and assistance relating to customs litigation in the field of pharma bulk and finished products

 

We provide strategic advisory services and legal opinions regarding all of the above areas relating to the interpretation of applicable provisions or litigation, including before the Council of State, the European Commission, European Court of Human Rights or the European Court of Justice.

Our approach

  • Recognised credibility with the public authorities
  • Understanding of all issues facing our clients for whom we develop tailored solutions: we go beyond providing expert advice and deal with the issues raised from a strategic perspective and after carrying out an overall assessment of the client's situation and priorities
  • Capacity to manage complex matters by multilingual lawyers belonging to an international alliance and mastering the concepts deriving from economic law, public law and European  law in order to help companies in the healthcare  product sector improve the management of their institutional environment and their relations with the public authorities, competitors, suppliers or customers
  • Our teams' access to CMS Bureau Francis Lefebvre's legal expertise (in particular, company law, contract law, employment law) and tax expertise

 
Methodological rigour: mobilisation of leading expertise and skills in the best interest of the client.

Our clients

A large number of pharmaceutical (drug and vaccine), biotechnology, medical device, and cosmetics companies, as well as hospitals, healthcare providers, research institutions and industry associations place trust in our firm for our advisory and litigation services.
Our clients range from established international drug and device groups with blockbuster products to smaller companies with a very specialised health activity.

Our team

Our dedicated lifesciences team is comprised of lawyers from several different practices who work together to provide a complete approach to our clients.

© CMS Bureau Francis Lefebvre 2010  
© CMS Bureau Francis Lefebvre 2010  Disclaimer | Privacy Statement | Sitemap